Quantile-Quantile (QQ) plots of GWMA results. Black circles indicate results seen at full set of genotyped and imputed SNPs. Blue circles indicate results seen after removal of SNPs in previously identified PBC-associated loci. After genomic control (GC) correction in each discovery cohort individually, the inflation factor was λ = 1.057 for all SNPs and λ = 1.043 with SNPs at established risk loci excluded, indicating no substantial departure of test statistics from their expected distribution. Note that even with established risk loci excluded, there is still deviation in the tail of the distribution, suggesting the presence of true associations within the dataset.
Cases

Controls
The sample size used in the discovery and validation cohorts in the current study. Discovery cohorts corresponded to data sets used in previously published North American, Italian and UK GWAS of PBC. [1] [2] [3] Functional Annotation *Regulatory region variants: the candidate variant is located in a regulatory region in proximity to the annotated gene (Supplementary Table S6 ); †Methyla on quan ta ve trait loci (mQTLs): the candidate variant is correlated to methylation related to the annotated gene (Supplementary Table S7 ); ᶲExpression quantitative trait loci (eQTLs): the candidate variant is correlated to expression of the annotated gene (see Supplementary Table S8) ; ‡Splice region variants: the candidate variant is predicted to alter slicing of the annotated gene (see Supplementary Table S5) ; ˠMissense variants: the candidate variant causes a non-synonymous change in the coding sequence of the annotated gene (Supplementary Table S5 ).
Supplementary Table 2: Loci achieving genome-wide level of significance in the discovery analysis
Discovery P-values were calculated using logistic regression of individual discovery datasets in ProbABEL followed by genomic control correction of individual discovery datasets in R and fixedeffects meta-analysis in META. Known indicates whether the risk locus has been identified in a previous study (with references). Note that 2p23.1 was implicated in Mells et al (2011) but failed to replicate. Note also that 13q14.3 has not been identified in previous studies but it is probably a spurious finding. SNP, single nucleotide polymorphism; A1, tested allele; f (A1), frequency of the tested allele; OR, odds ratio; CD, Crohn disease; UC, ulcerative colitis; RA, rheumatoid arthritis; MS, multiple sclerosis; CeD, celiac disease; SSc, systemic sclerosis; SjS, Sjogren syndrome; SLE, systemic lupus erythematosus; PSC, primary sclerosing cholangitis; JIA, juvenile inflammatory arthritis; T1D, type 1 diabetes mellitus; Pso, psoriasis. 
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